New blood test could show if prostate cancer treatment is failing - The discovery could lead to personalised treatments for ...
Health-evidence reviewers reverse recommendation on a blood test that detects a biomarker of a common cancer after decades of ...
Prostate-specific antigen (PSA) blood testing likely reduces the risk of death from prostate cancer, found a new review ...
A major review of nearly 800,000 men has found prostate cancer screening using a specific test is likely to reduce deaths ...
Screening for prostate cancer using blood tests likely reduces the number of men dying from the disease, a new study has ...
A landmark review of nearly 800,000 men has found that PSA blood tests do reduce prostate cancer deaths — a shift from ...
Blood tests to detect potential signs of prostate cancer likely reduce the risk of dying from prostate cancer, an updated ...
ORLANDO, Fla. (Ivanhoe Newswire) - Prostate cancer is the second leading cause of death in men right behind heart disease. Patients with this cancer often don’t find out until the disease has advanced ...
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)-- Veracyte, Inc. (Nasdaq: VCYT), a leading genomic diagnostics company, and University College London (UCL) today announced that data published online in ...
Testing the molecular profile of prostate tumours identifies which patients with advanced prostate cancer are more likely to benefit from a chemotherapy treatment called docetaxel and live longer, ...